• Profile
Close

Near point-of-care HIV viral load: Targeted testing at large facilities

Journal of Acquired Immune Deficiency Syndromes Jan 19, 2021

Ganesh P, Heller T, Chione B, et al. - Although point-of-care (POC) technologies in resource-limited settings can circumvent challenges of centralized laboratory testing, improving clinical management, scaling up POC modalities has been inhibited by higher device costs and uncertain indications for use. In this study, researchers sought to address this gap via examining the feasibility and cost of targeted near-POC viral load (VL) testing in 2 large HIV clinics in Lilongwe, Malawi. Of 2,813 near-POC VL tests conducted, 1,511 (54%) tests were for patients for whom results and reason for the test were documented. Findings suggest the feasibility of targeted, near-POC VL testing and its consistent ability to allow prompt clinical action. Further reduction in the difference between the “all-in” cost of near-POC VL and centralized testing of $5.09 could be done in an optimized national program by combining targeted near-POC testing and centralized testing.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay